International Society for Stem Cell Application presents an unparalleled gathering of experts in Istanbul, Turkey.
Miami, Florida – The International Society for Stem Cell Application (ISSCA) is thrilled to unveil the remarkable roster of speakers for the highly anticipated Regenerative Medicine World Congress 2023. Set to take place from November 10 to 12, 2023, at the exquisite Crowne Plaza Istanbul Florya Hotel in Istanbul, Turkey, the congress is primed to be a convergence of minds dedicated to the advancement of stem cell therapy and regenerative medicine.
With over 35 countries represented, the Regenerative Medicine World Congress 2023 promises to be an extraordinary platform for knowledge exchange and scientific exploration. Distinguished doctors and scientists from across the globe will unite to discuss the latest developments in stem cell therapy and regenerative medicine through evidence-based research presentations.
Delegates attending the congress will have the unique opportunity to engage with more than 25 world-renowned medical experts who will present their insights and findings on a spectrum of issues related to this groundbreaking field. This three-day event is designed to foster interactive sessions, enabling attendees to deepen their understanding and broaden their perspectives on the applications of stem cell technology in various medical conditions.
Dr. Salih Yildirim, President of ISSCA, expressed his enthusiasm, saying, “I am delighted to witness the convergence of global medical experts in Istanbul. The Regenerative Medicine World Congress 2023 is an occasion to showcase our commitment to fostering international collaboration, sharing knowledge, and propelling medical progress.”
Echoing this sentiment, Benito Novas, an esteemed figure in the realm of regenerative medicine and the head of Public Relations for GSCG and ISSCA, highlighted ISSCA’s mission: “Our aim at ISSCA is to facilitate an environment of global collaboration and knowledge exchange. The Regenerative Medicine World Congress 2023 epitomizes this objective, offering a unique opportunity for professionals to engage in critical discussions, share insights, and collectively contribute to the advancement of medical science.”
A central highlight of the congress is the immersive hands-on training, facilitated by distinguished ISSCA-certified instructors. Participants will embark on an in-depth exploration of clinical and aesthetic applications of stem cell therapy during an intensive single-day workshop on November 12th. This comprehensive training, designed exclusively for those who secure the all-access package (limited to 20 seats), is guided by experts with extensive experience. Attendees are expected to acquire tangible skills that are readily applicable in their medical practice.
The congress will be inaugurated by Dr. Dayeong Kim from Korea and the President of ISSCA, Dr. Salih Yildirim. Their opening address will set the tone for an array of engaging sessions led by esteemed experts. Topics will span diverse medical conditions and real-world case studies, showcasing the application of stem cell therapy across various contexts.
Among the impressive lineup of speakers are luminaries such as:
– Dr. Dayeong Kim (Korea)
– Dr. Salih Yildirim (Turkey)
– Dr. Alan Gaveck (USA)
– Dr. Serdar Kabatas (Turkey)
– Dr. Yanti Kushmiran (Indonesia)
– Dr. Hilmi Karadeniz (Turkey)
– Dr. Roni Moya (Portugal)
– Dr. Tunç Akkoç (Turkey)
– Dr. Erdinc Civelek (Turkey)
– Dr. Mehmet Veli Karaaltın (Turkey)
– Dr. Ayman El Attar (USA)
– Prof. Utku Ates (Turkey)
– Dr. Fikrettin Şahin (Turkey)
– Dr. Emel Polat (Turkey)
– Dr. Patria Gonzalez (Dominican Republic)
– Dr. Ferda Alpaslan Pinarli (Turkey)
– Dra. Silvina Pastrana (Argentina)
– Dr. Samy Joheir (Belgium)
– Dr. Ahmet Doğan (Turkey)
– Dr. Jorge Elias (Argentina)
– Dr. Roland Neff (Switzerland)
– Prof. Aygen Türkmen (Turkey)
The Regenerative Medicine World Congress 2023 is an unparalleled opportunity for professionals to enrich their expertise, expand their network, and stay at the forefront of cutting-edge advancements in the field. To register and access detailed event information, please visit https://www.issca.us/turkey-world-conference-2023/
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The mission of the International Stem Cell Certification Agency (ISSCA) is to establish itself as a global leader in regenerative medicine certification, education, research, and training.
ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
